Healthy Clinical Trial
Official title:
WILD 5 Wellness: A 90-Day Intervention (WILD = Wellness Interventions for Life's Demands)
Verified date | April 2019 |
Source | University of Texas at Austin |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to explore the efficacy and feasibility of an integrated, prescriptive, and trackable wellness intervention combining five wellness elements including exercise, mindfulness, sleep, social connectedness, and nutrition.
Status | Completed |
Enrollment | 150 |
Est. completion date | August 13, 2018 |
Est. primary completion date | June 12, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Adults (18 years of age or older) - English- speaking - Access to a reliable Internet-enabled computer - Possess basic computer skills - Self-identify as having at least one of the health conditions listed on the online registration form or - Self-identify as a community participant without a health condition. Exclusion Criteria: - Acutely suicidal and/or actively psychotic - Non-English speaking - Do not have access to an Internet-enabled computer - Report a lack of basic computer skills - Pregnant or plan to get pregnant during the next 90-days. |
Country | Name | City | State |
---|---|---|---|
United States | University of Texas at Austin School of Nursing | Austin | Texas |
Lead Sponsor | Collaborator |
---|---|
University of Texas at Austin |
United States,
Cooney GM, Dwan K, Greig CA, Lawlor DA, Rimer J, Waugh FR, McMurdo M, Mead GE. Exercise for depression. Cochrane Database Syst Rev. 2013 Sep 12;(9):CD004366. doi: 10.1002/14651858.CD004366.pub6. Review. — View Citation
Cruwys T, Dingle GA, Haslam C, Haslam SA, Jetten J, Morton TA. Social group memberships protect against future depression, alleviate depression symptoms and prevent depression relapse. Soc Sci Med. 2013 Dec;98:179-86. doi: 10.1016/j.socscimed.2013.09.013. — View Citation
Fardet A, Boirie Y. Associations between food and beverage groups and major diet-related chronic diseases: an exhaustive review of pooled/meta-analyses and systematic reviews. Nutr Rev. 2014 Dec;72(12):741-62. doi: 10.1111/nure.12153. Epub 2014 Nov 18. Re — View Citation
Hui SK, Grandner MA. Associations between Poor Sleep Quality and Stages of Change of Multiple Health Behaviors among Participants of Employee Wellness Program. Prev Med Rep. 2015 Jan 1;2:292-299. — View Citation
Jeste DV, Palmer BW, Rettew DC, Boardman S. Positive psychiatry: its time has come. J Clin Psychiatry. 2015 Jun;76(6):675-83. doi: 10.4088/JCP.14nr09599. — View Citation
Williams JM, Crane C, Barnhofer T, Brennan K, Duggan DS, Fennell MJ, Hackmann A, Krusche A, Muse K, Von Rohr IR, Shah D, Crane RS, Eames C, Jones M, Radford S, Silverton S, Sun Y, Weatherley-Jones E, Whitaker CJ, Russell D, Russell IT. Mindfulness-based c — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Patient Health Questionnaire-9 (PHQ-9) | A self-reported depression scale used to assess severity of depression. | 0, 30, and 90 days - Primary endpoint is 30 days | |
Primary | Change in Generalized Anxiety Disorder-7 (GAD-7) | A self-reported questionnaire used to assess anxiety symptoms. | 0, 30, and 90 days - Primary endpoint is 30 days | |
Primary | Change in World Health Organization-5 (WHO-5) | A brief scale that measures mental well- being. | 0, 30, and 90 days - Primary endpoint is 30 days | |
Primary | Change in The Mindful Attention Awareness Scale (MAAS) | A popular measure of mindfulness. | 0, 30, and 90 days - Primary endpoint is 30 days | |
Primary | Change in The Sleep Condition Indicator (SCI) | A brief scale that evaluates insomnia disorder. | 0, 30, and 90 days - Primary endpoint is 30 days | |
Primary | Change in The Social Connectedness Scale (SCS) | A brief scale that assesses the degree to which respondents feel connected to others. | 0, 30, and 90 days - Primary endpoint is 30 days | |
Primary | Change in Eating and Appraisal Due to Emotions and Stress (EADES) | A scale assessing how individuals cope with and appraise stress in relation to food and eating. | 0, 30, and 90 days - Primary endpoint is 30 days | |
Primary | Change in The Mediterranean-Dietary Approaches to Stop Hypertension (DASH) Intervention for Neurodegenerative Delay (MIND) | A combination of the Mediterranean and DASH (Dietary Approaches to Stop Hypertension) diets shown to lower a person's risk of developing Alzheimer's disease. | 0, 30, and 90 - Primary endpoint is 30 days | |
Primary | Change in The Brief Pain Inventory (BPI) | A measurement tool for assessing clinical pain. | 0, 30, and 90 days - Primary endpoint is 30 days | |
Primary | Change in The Sheehan Disability Scale (SDS) | A measurement tool for assessing functional impairment in three inter-related domains: work/school, social and family life. | 0, 30, and 90 days - Primary endpoint is 30 days | |
Primary | Change in The Endicott Work Productivity Scale (EWPS) | A brief self-report questionnaire designed to obtain a sensitive measure of work productivity. | 0, 30, and 90 days - Primary endpoint is 30 days | |
Primary | Change in Cognitive and Physical Functioning Questionnaire (CPFQ) | A brief scale that measures cognitive and executive dysfunction. | 0, 30, and 90 days - Primary endpoint is 30 days | |
Primary | Change in The WILD 5 Wellness Scale (W5WS) | A brief scale designed specifically for this project to measure wellness. | 0, 30, and 90 days - Primary endpoint is 30 days | |
Primary | Change in The WILD 5 Wellness Effort Scale (W5ES) | A scale designed specifically for this project to measure weekly adherence with program elements. | 0, 30, and 90 days - Primary endpoint is 30 days | |
Primary | Change in The WILD 5 Wellness Elements Scale | A scale designed specifically for this project to measure elements of depression, anxiety, wellbeing, mindfulness, sleep quality, social connectedness, emotional eating, diet practices, pain, disability, work productivity, happiness, enthusiasm, resilience, and optimism. | 0, 30, and 90 days - Primary endpoint is 30 days | |
Primary | The Post-Program Participant Questionnaire | A brief post study survey that captures participants' opinions about WILD 5 Wellness: 90-Day Intervention, and subjective ranking of their overall wellness. | 90 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |